Your session is about to expire
← Back to Search
Stem Cell Transplantation for Multiple Myeloma
Study Summary
This trial will test if high-dose chemotherapy followed by ASCT affects thinking skills and brain anatomy/function in adults with multiple myeloma.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are currently using drugs or have a history of drug use, as confirmed by medical records or your own report.I have been diagnosed with a major psychiatric disorder like depression, bipolar, or schizophrenia.You have metal implants, a pacemaker, stents, or are claustrophobic, which could prevent you from having an MRI.I have had cancer before, but not skin cancer.My multiple myeloma is in remission.I have been on stable doses of my depression or anxiety medication for over 2 months.I am between 60 and 75 years old.I am scheduled for high-dose chemotherapy and a stem cell transplant.I have signs or symptoms of brain cancer, confirmed by a doctor or MRI.I have a history of serious brain conditions or injuries.I can speak and understand English well enough for study requirements.I speak English very well, even though it's not my first language.
- Group 1: rsfMRI + Neurocognitive Tests
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the eligibility criteria of this study limited to participants under 55 years old?
"Qualified applicants for this medical experiment must be between 60 and 75 years of age. Other trials exist that involve individuals under 18 (39) or 65 plus (794)."
Are additional participants being taken into consideration for this experiment?
"Information on clinicaltrials.gov reveals that this medical study is not presently enrolling participants. Initially posted on March 27th 2018, the trial was last modified on March 9th 2022. Despite its inactivity as of now, there are 808 other trials currently seeking patients for their research."
What qualifications do prospective participants need to fulfill in order to join this investigation?
"This research is searching for 18 individuals diagnosed with multiple myeloma between the ages of 60 and 75. This study requires that applicants are able to communicate effectively in English, have been evaluated according to International Myeloma Working Group Criteria and be scheduled for high-dose chemotherapy and ASCT treatments. Those whose native tongue is not English must demonstrate they possess a proficient level of comprehension by answering "very well" when prompted with the US Census' question on language fluency."
Share this study with friends
Copy Link
Messenger